Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qibai Pingfei granules for stable COPD (Qi deficiency with phlegm and blood stasis pattern) – Phase II RCT
CTR20231952Phase 2Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Qibai Pingfei Granules in chronic obstructive pulmonary disease (COPD), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Sep 2023; status: active.
02
Drugs
Qibai Pingfei Granules
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20231952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231952.